Antibiotice S.A.

BVB:ATB Stock Report

Market Cap: RON 1.4b

Antibiotice Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Ioan Nani

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure17.4yrs
CEO ownershipn/a
Management average tenure5.1yrs
Board average tenure1.2yrs

Recent management updates

Recent updates

Analysis Article • Apr 25

Antibiotice (BVB:ATB) Is Paying Out Less In Dividends Than Last Year

Antibiotice S.A.'s ( BVB:ATB ) dividend is being reduced by 75% to RON0.0206 per share on 8th of October, in comparison...
Analysis Article • Apr 04

Antibiotice (BVB:ATB) Will Pay A Smaller Dividend Than Last Year

The board of Antibiotice S.A. ( BVB:ATB ) has announced that the dividend on 8th of October will be reduced by 75% from...
Analysis Article • Nov 23

Is Antibiotice (BVB:ATB) Using Too Much Debt?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
Analysis Article • Jun 07

Market Might Still Lack Some Conviction On Antibiotice S.A. (BVB:ATB) Even After 25% Share Price Boost

Despite an already strong run, Antibiotice S.A. ( BVB:ATB ) shares have been powering on, with a gain of 25% in the...
Analysis Article • Jan 30

Antibiotice S.A. (BVB:ATB) Looks Just Right With A 26% Price Jump

Despite an already strong run, Antibiotice S.A. ( BVB:ATB ) shares have been powering on, with a gain of 26% in the...
Analysis Article • Jan 13

We Think Antibiotice (BVB:ATB) Can Manage Its Debt With Ease

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article • Aug 16

These 4 Measures Indicate That Antibiotice (BVB:ATB) Is Using Debt Safely

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article • Jun 08

Is Antibiotice (BVB:ATB) A Risky Investment?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article • Mar 10

These 4 Measures Indicate That Antibiotice (BVB:ATB) Is Using Debt Extensively

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article • Feb 11

Tread With Caution Around Antibiotice S.A.'s (BVB:ATB) 5.8% Dividend Yield

Today we'll take a closer look at Antibiotice S.A. ( BVB:ATB ) from a dividend investor's perspective. Owning a strong...
Analysis Article • Jan 12

Calculating The Intrinsic Value Of Antibiotice S.A. (BVB:ATB)

Does the January share price for Antibiotice S.A. ( BVB:ATB ) reflect what it's really worth? Today, we will estimate...
Analysis Article • Dec 16

Are Antibiotice's (BVB:ATB) Statutory Earnings A Good Guide To Its Underlying Profitability?

Broadly speaking, profitable businesses are less risky than unprofitable ones. Having said that, sometimes statutory...
Analysis Article • Nov 24

Is Antibiotice (BVB:ATB) Using Too Much Debt?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...

CEO

Ioan Nani (67 yo)

17.4yrs
Tenure

Mr. Ioan Nani is the CEO and Non-Independent Director at Antibiotice S.A. since 2009. Mr. Nani served as General Manager, General Director and had been its Chairman since April 15, 2025 until June 2025 and...

Leadership Team

NamePositionTenureCompensationOwnership
Ioan Nani
CEO & Director17.4yrsno datano data
Paula-Luminita Coman
Executive Director of Financial & CFOno datano datano data
Eugen Osadet
Engineering & Investment Director26.4yrsno datano data
Cornelia Moraru
Investors Relation Officer and Executive Director of Technical & Production3.4yrsno datano data
Liviu Vatavu
Executive Director of Legal & Corporate Governance6.5yrsno datano data
Ovidiu Bataga
Executive Director of National Salesno datano datano data
Mihaela Murariu
Executive Director of Human Resource3.8yrsno datano data
Stefania Alexandru
Deputy General Managerless than a yearno datano data
5.1yrs
Average Tenure
56.5yo
Average Age

Experienced Management: ATB's management team is seasoned and experienced (5.1 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Ioan Nani
CEO & Director17.4yrsno datano data
Ionut-Sebastian Iavor
President of the Board2.4yrsno datano data
Catalin Lungu
Independent Director2.4yrsno datano data
Laura Cristina Bogdan
Non-Independent Board Member1.2yrsno datano data
Andrei Novac
Independent Board Member1.2yrsno datano data
Corina Vulpes
Independent Board Member1.2yrsno datano data
Madalina-Anca Bonifate
Independent Directorless than a yearno datano data
1.2yrs
Average Tenure
50yo
Average Age

Experienced Board: ATB's board of directors are not considered experienced ( 1.2 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/17 15:38
End of Day Share Price 2026/06/17 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Antibiotice S.A. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Vladimira UrbankovaErste Group Bank AG
Daniela MandruSwiss Capital SA
Andrei RadulescuSwiss Capital SA